ClassID:

94156

C07D211/28 - CPC Classification

Classification description:

Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached

Recent Application in this class:
#1
20250250230
2025-08-07

HETEROCYCLIC COMPOUND

#2
20240174611
2024-05-30

SUBSTITUTED CYCLIC MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME

#3
20230331674
2023-10-19

N-((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)NAPHTHALENE-2-SULFONAMIDE FOR THE TREATMENT OF CANINE COGNITIVE DYSFUNCTION AND OTHER FORMS OF DEMENTIA IN DOGS

#4
20230312471
2023-10-05

CHEMICAL PROBES AND INHIBITORS FOR POLYPEPTIDES OF SARS CORONAVIRUSES

#5
20230183239
2023-06-15

ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES THEREOF

#6
20230181742
2023-06-15

AMINE-CONTAINING TRANSFECTION REAGENTS AND METHODS FOR MAKING AND USING SAME

#7
20230159446
2023-05-25

Methods and Compositions for Targeting Tregs using CCR8 Inhibitors

#8
20230038589
2023-02-09

Methods and compositions for targeting Tregs using CCR8 inhibitors

#9
20230026611
2023-01-26

ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS

#10
20230000851
2023-01-05

ERAP1 MODULATORS

#11
20220380314
2022-12-01

SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

#12
20220354949
2022-11-10

NOVEL COMPOUNDS

#13
20220177425
2022-06-09

SMALL MOLECULES FOR CANCER THERAPY THAT REDUCE THE EXPRESSION OF TRANSCRIPTION FACTORS KLF5 AND EGR-1

#14
20210198200
2021-07-01

Compounds and compositions for intracellular delivery of agents

#15
20210196695
2021-07-01

K-Ras modulators

#16
20210107871
2021-04-15

BIARYL SULFONAMIDE DERIVATIVE HAVING FILOVIRUS CELL ENTRY INHIBITION ACTIVITY

#17
20210024462
2021-01-28

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#18
20200392077
2020-12-17

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

#19
20200291024
2020-09-17

ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES THEREOF

#20
20200255373
2020-08-13

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#21
20200061197
2020-02-27

Amine-containing transfection reagents and methods for making and using same

#22
20200039935
2020-02-06

Chemical Process for Preparing Pyrimidine Derivatives and Intermediates Thereof

#23
20190276395
2019-09-12

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

#24
20190233375
2019-08-01

Synthesis of inhibitors of EZH2

#25
20190106448
2019-04-11

Manganese (III) catalyzed C—H aminations

#26
20190077790
2019-03-14

4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors

#27
20190055272
2019-02-21

Prodrugs of phenolic TRPV1 agonists

#28
20180371110
2018-12-27

Modified cyclodextrins for the selective sequestration of fentanyl related compounds and uses thereof

#29
20180289683
2018-10-11

K-Ras modulators

#30
20180263934
2018-09-20

Necrosis inhibitors

#31
20180200374
2018-07-19

Amine-containing transfection reagents and methods for making and using same

#32
20180127361
2018-05-10

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#33
20180086707
2018-03-29

Disubstituted piperidines as butyrylcholinesterase inhibitors

#34
20180057457
2018-03-01

Chemical Process for Preparing Pyrimidine Derivatives and Intermediates Thereof

#35
20170362259
2017-12-21

Process and intermediates for making tubulysin analogs

#36
20170183307
2017-06-29

Method for producing synthetic pentapeptide

#37
20170107208
2017-04-20

Synthetic process

#38
20170001955
2017-01-05

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

#39
20150266890
2015-09-24

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#40
20150174260
2015-06-25

Amine-containing transfection reagents and methods for making and using same

#41
20150080369
2015-03-19

Compounds

#42
20140336158
2014-11-13

NKantagonists

#43
20140235628
2014-08-21

Inhibitors of the renal outer medullary potassium channel

#44
20140011996
2014-01-09

N-piperidinyl acetamide derivatives as calcium channel blockers

#45
20130181107
2013-07-18

Furnace mount

#46
20130137720
2013-05-30

Histone demethylase inhibitors and methods for using the same

#47
20130109718
2013-05-02

1-CYCLOALKYL- OR 1-HETEROCYCLYL-HYDROXYIMINO-3-PHENYL-PROPANES

#48
20130065926
2013-03-14

N-piperidinyl acetamide derivatives as calcium channel blockers

#49
20130045977
2013-02-21

TGF-β signal transduction inhibitor

#50
20130023503
2013-01-24

NK1 antagonists

#51
20120238574
2012-09-20

(1, 1, 1,3,3,3-hexafluoro-2 hydroxypropan-2-yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis

#52
20120172358
2012-07-05

GPCR Agonists

#53
20120149909
2012-06-14

-substituted--phenylethylsulfonamides for the identification of biological and pharmacological activity

#54
20120136073
2012-05-31

Amine-Containing Transfection Reagents and methods for making and using same

#55
20120122920
2012-05-17

LIBRARIES OF N-SUBSTITUTED-N-PHENYLETHYLSULFONAMIDES FOR DRUG DISCOVERY

#56
20120122710
2012-05-17

LIBRARIES OF N-SUBSTITUTED-N-PHENYLETHYLSULFONAMIDES FOR THE IDENTIFICATION OF BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY

#57
20120035214
2012-02-09

RENIN INHIBITORS

#58
20110160176
2011-06-30

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

#59
20110105485
2011-05-05

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

#60
20110098468
2011-04-28

NKantagonists

#61
20100204213
2010-08-12

Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders

#62
20100087442
2010-04-08

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#63
20100063081
2010-03-11

CPCR Agonists

#64
20090306175
2009-12-10

Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor

#65
20090298883
2009-12-03

N-piperidinyl acetamide derivatives as calcium channel blockers

#66
20090286765
2009-11-19

Inhibitors of GLYT1 transporters

#67
20090285849
2009-11-19

Thiosemicarbazones as anti-virals and immunopotentiators

#68
20090275556
2009-11-05

Aryl sulfonamides useful as inhibitors of chemokine receptor activity

#69
20080200461
2008-08-21

MODULATORS OF ACETYL-COENZYME A CARBOXYLASE AND METHODS OF USE THEREOF

#70
20080096922
2008-04-24

Novel Sulfonamide derivative

#71
20080090828
2008-04-17

N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines

#72
20080085894
2008-04-10

α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors

#73
20080045493
2008-02-21

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine Dreceptor

#74
20080027035
2008-01-31

Dpp-Iv Inhibitors

#75
20070249625
2007-10-25

Il-8 Receptor Antagonists

#76
20070203183
2007-08-30

Diaryl piperidines as CB1 modulators

#77
20070112022
2007-05-17

Piperidine derivatives as ccr5 receptor modulators

#78
20070043080
2007-02-22

Substituted anilinic piperidines as MCH selective antagonists

#79
20060223861
2006-10-05

Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics

#80
20060217418
2006-09-28

Substituted alkyl amido piperidines

#81
20060205944
2006-09-14

Preparation of acid addition salts of amine bases by solid phase—gas phase reactions

#82
20060199815
2006-09-07

NKantagonists

#83
20060166962
2006-07-27

N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines

#84
20060135504
2006-06-22

N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines

#85
20060122166
2006-06-08

Cyclohexyl compounds as CCR5 antagonists

#86
20060111303
2006-05-25

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#87
20060106067
2006-05-18

Fused benzene derivative and use

#88
20060084649
2006-04-20

Substituted alkyl amido piperidines

#89
20060052408
2006-03-09

Cyclopropyl compounds as ccr5 antagonists

#90
20060041139
2006-02-23

Substituted alkyl amido piperidines

#91
20060030599
2006-02-09

Sulphonamide derivatives

#92
20060025442
2006-02-02

Acylated piperidine derivatives as melanocortin-4 receptor agonists

#93
20050227987
2005-10-13

11β-hydroxysteroid dehydrogenase inhibitors

#94
20050171159
2005-08-04

Synthesis of (4-bromophenyl)(4-piperidyl)methanone-(Z)-O-ethyloxime and salts

#95
20050171098
2005-08-04

MCH antagonists and their use in the treatment of obesity

#96
20050143372
2005-06-30

Compounds, pharmaceutical compositions and methods of use therefor

#97
20050107397
2005-05-19

Sulfonamide derivatives as D3-receptor ligands

#98
20050096325
2005-05-05

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

#99
20050085518
2005-04-21

Aryl sulfonamides useful as inhibitors of chemokine receptor activity

#100
20050070582
2005-03-31

Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders

#101
20050069555
2005-03-31

Thiosemicarbazones as anti-virals and immunopotentiators

#102
20050035267
2005-02-17

Furnace mount and method of installation

#103
20050035266
2005-02-17

Furnace mount